ad image

IssueQ12022

1 / 2
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Nigel Walker

Nice Insight

PAO-03-022-NI-08Mar 23, 2022
How Artificial Intelligence May Drive the Future of Clinical Trials
Column: Clinical Trials

How Artificial Intelligence May Drive the Future of Clinical Trials

James Grote

Nice Insight

PAO-03-022-NI-01Mar 23, 2022
New FDA Guidance on Real World Evidence/Real World Data
Column: Regulatory Spotlight

New FDA Guidance on Real World Evidence/Real World Data

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-022-NI-03Mar 23, 2022
Alzheimer Drug Still Controversial
Column: New Drug Watch

Alzheimer Drug Still Controversial

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-022-NI-04Mar 23, 2022
mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?
Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PAO-03-022-NI-02Mar 23, 2022
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Column: Investment

2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out

Danielle Alvarez

Pharma's Almanac

PAO-03-022-NI-07Mar 23, 2022
Expanding the Cell and Gene Therapy Ecosystem in Philadelphia
Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

David Alvaro, Ph.D.

Pharma's Almanac

PAO-12-21-CL-05Mar 23, 2022
HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice
Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

evitria AG

PAO-03-022-CL-22Mar 22, 2022
10 Promising Biotechs Aiming to Transform Medicine
Biotechs

10 Promising Biotechs Aiming to Transform Medicine

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

PA564Mar 22, 2022
Unique Vector Expression Technologies for Boosting Protein Production in E. coli
Biomanufacturing

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

PAO-02-022-CL-16Mar 20, 2022
Changing the Future of Cell Culture and Accelerating Next-Generation Therapies
Cell Culture

Changing the Future of Cell Culture and Accelerating Next-Generation Therapies

A.J. Mellott, Ph.D.; Scott Leigh

Ronawk

PAO-02-022-CL-20Mar 20, 2022
Overcoming Analytical Challenges for Gene Therapies
Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Jennifer Chadwick, Ph.D.

ProtaGene

PAO-02-022-CL-14Mar 20, 2022
Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?
COVID-19 Vaccines

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-03-022-NI-05Mar 18, 2022
Streamlining Process Validation for Drug Substance Manufacturing
Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

Gerhard Noessner, Ph.D.; Juergen Utz, Ph.D.; Juergen Bank, Ph.D.

Fareva

PAO-02-022-CL-19Mar 15, 2022
Global Investment Trends and Getting Noticed by PE/VC Firms
Investment

Global Investment Trends and Getting Noticed by PE/VC Firms

Iesan Tsai

Kiri Capital

PAO-02-022-CL-15Mar 15, 2022
Sterile Injectables Device and Packaging Trends
Sterile

Sterile Injectables Device and Packaging Trends

James Grote

Nice Insight

PAO-02-022-NI-01Mar 14, 2022
The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances
Mesenchymal Stem Cells

The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances

David Alvaro, Ph.D.

Pharma's Almanac

PAO-12-21-NI-01Mar 12, 2022
The Limitless Potential of Thin Film Freezing
Solubility

The Limitless Potential of Thin Film Freezing

Glenn Mattes

TFF Pharmaceuticals, Inc.

PAO-01-22-CL-04Mar 12, 2022
Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases
Neurodegenerative Diseases

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Rob Etherington

PAO-01-22-CL-06Mar 12, 2022
Moving Beyond the Industrialization of MSCs
Mesenchymal Stem Cells

Moving Beyond the Industrialization of MSCs

Tim Kelly, Ph.D.

RoosterBio

PAO-12-21-CL-06Mar 12, 2022
1 / 2